Video of a T-cell attacking a cancer cell.
February 15, 2017 (YouTube)
Video of a T-cell attacking a cancer cell. Read More 
At the Bench-Glioblastoma: Immunotherapy for Glioblastoma Has a New and Potentially Powerful Target
April 5, 2018 (Neurology Today) A protein associated with glioblastoma multiform (GBM) has been identified and in experiments has proven to be a promising new target for immunotherapy against these …
At the Bench-Glioblastoma: Immunotherapy for Glioblastoma Has a New and Potentially Powerful Target Read More
This ‘genetic switch’ could help to fight cancer
April 27, 2018 (Medical News Today) T cells, a type of white blood cell, have an innate ability to recognize, attack and kill cancer cells. However, it is very apparent …
This ‘genetic switch’ could help to fight cancer Read More
Immunotherapy Promising for Slowing Progression of ALS
June 4, 2018 (HealthDay News) Positive results seen for autologous infusions of expanded regulatory T lymphocytes in three patients MONDAY, June 4, 2018 (HealthDay News) — A new immunotherapy appears …
Immunotherapy Promising for Slowing Progression of ALS Read More
New Study Finds that Lowering Cholesterol Improves Immunotherapy
May 19, 2018 (Medical News Today) This study was published in the Journal of Experimental Medicine. It discovered that when cholesterol levels are decreased, cancer fighting immunotherapy is more effective. …
New Study Finds that Lowering Cholesterol Improves Immunotherapy Read More
Combo of Chemo & Immunotherapy Determined Feasible in Metastatic Bladder Cancer
April 11, 2018 (HealthDay News) One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab Gemcitabine and cisplatin (GC) plus ipilimumab is associated with a 69 percent objective …
Combo of Chemo & Immunotherapy Determined Feasible in Metastatic Bladder Cancer Read More
CAR T-Cell Immunotherapy Named Clinical Advance of the Year by ASCO
In January, ASCO published its 13th annual report in Clinical Cancer Advances 2018, and named chimeric antigen receptor (CAR) T-cell immunotherapy as its Advance of the Year. This repost highlights …
CAR T-Cell Immunotherapy Named Clinical Advance of the Year by ASCO Read More
CAR T-Cell Therapy HCP Guide – Future Implications for CAR T-Cell Therapy
What’s Next for CAR T-Cell Therapy? Top issues for researchers and clinicians utilizing CAR T-cell therapy include: Shortening the manufacturing time and vein-to-vein time, scaling productivity, managing side effects, and …
CAR T-Cell Therapy HCP Guide – Future Implications for CAR T-Cell Therapy Read More
The Goal of Armored CAR T Cells
Dr. Renier Brentjens, MD, PhD from the Memorial Sloan Kettering Cancer Center, discusses the goal of armored CAR T-cells. He talks about how the researchers add additional genets to the …
The Goal of Armored CAR T Cells Read More
‘Cross-dressing’ cells may improve cancer treatment
January 23, 2018 (Medical News Today) A group of researchers from Switzerland are now focused on improving ‘dendritic cell vaccines’, which are an important part of the immune system that …
‘Cross-dressing’ cells may improve cancer treatment Read More